Skip to content

Healthcare Data News

News from the healthcare data industry

  • Submit News
  • Home
  • Industry News
  • Competitor News
  • Partner and Collaborator News
Healthcare Data News
  • Home
  • Industry News
  • Competitor News
  • Partner and Collaborator News
  • Submit News

Category: Oncology

Posted on May 31, 2022June 6, 2022 Collaborations Competitor News Data Partnership Government/Regulatory Oncology

GRAIL Announces Collaboration With U.S. Department of Veterans Affairs and the Veterans Health Foundation to Evaluate Galleri® Multi-Cancer Early Detection Test

ollaboration Will Provide Galleri Test to 10,000 Veterans Across the U.S. Over the Next Three Years; VA Pittsburgh Healthcare System Announced as First of Approximately 10 Participating Sites Collaboration is...

Posted on May 26, 2022May 30, 2022 Competitor News Oncology RWE Study

Flatiron Health Announces Research to be Presented at American Society of Clinical Oncology 2022 Annual Meeting

May 26, 2022 05:30 PM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–Flatiron Health today announced three Flatiron-authored abstracts have been accepted for poster discussion and presentations at the 2022 American Society of Clinical...

Posted on May 26, 2022May 27, 2022 Competitor News Oncology

Global Oncology Trends 2022

Outlook to 2026 Institute Report May 26, 2022 Web Summary Oncology is the leading therapy area for innovation – in terms of the level of clinical trial activity, number of...

Posted on May 23, 2022May 23, 2022 Collaborations Competitor News Data Partnership Oncology

UPenn researchers found reduced absorption of Janssen’s Balversa in eligible bladder cancer patients

NEW YORK – It’s been three years since the US Food and Drug Administration agreed Janssen’s Balversa (erdafitinib) for patients with advanced bladder tumors harboring FGFR3 or FGFR2 gene alterations, however a...

Posted on May 22, 2022May 23, 2022 Collaborations Data Partnership Oncology Partner and Collaborator News RWE Study

Patient- And Provider-Level Predictors of Survival Among Patients With Metastatic Renal Cell Carcinoma Initiating Oral Anticancer Agents

ABSTRACT PURPOSE: In an era of rapid expansion of FDA approvals for oral anticancer agents (OAAs), it is important to understand the factors associated with survival among real-world populations, which...

Posted on May 18, 2022May 20, 2022 Competitor News Oncology

Dr Miruna Sasu Discusses the Transformative Power of Real-world Data

Miruna Sasu, PhD, MBA, president and CEO of COTA Healthcare, discusses the medicines discovery process and how real-world data can be used to evaluate patient and tumor response to treatment...

Posted on May 17, 2022 Competitor News Oncology Product Updates

OncoHealth™ Unveils Real-World Evidence Dashboard for Pan Tumor, Immunotherapy Research

Powered by Real-World Oncology Data, DashIO™ Enables Researchers to Conduct Comparative Effectiveness Research and Market Performance Analyses ATLANTA, May 16, 2022 /PRNewswire/ — OncoHealth, the leading digital health company dedicated to oncology, unveiled,...

Posted on May 12, 2022May 16, 2022 Competitor News Oncology Product Updates

Verana Health Launches Urology Qdata Insights Offerings at American Urological Association Annual Meeting

Qdata Prostate Cancer is Verana Health’s first disease-specific data module for urology to help inform research for prostate cancer care SAN FRANCISCO, May 12, 2022 /PRNewswire/ — Verana Health®—a digital health company elevating...

Posted on May 9, 2022 Clinical Trials Collaborations Competitor News Data Partnership Oncology Pharma

Aadi Bioscience Announces Collaborations with Next Generation Sequencing Leaders

Company enters into collaborations with leading next generation sequencing (NGS) companies to facilitate trial enrollment for PRECISION 1, the Company’s Phase 2 registrational trial Collaborations will expedite identification of advanced...

Posted on May 5, 2022 Academic Collaborations Data Partnership Oncology Partner and Collaborator News Pharma

RefleXion Announces Real-World Evidence Outcomes Registry to Evaluate Treatment Impact on all Stages of Cancer

PREMIER registry to enroll a minimum of 750 patients and include all solid tumor cancers May 03, 2022 10:42 AM Eastern Daylight Time HAYWARD, Calif.–(BUSINESS WIRE)–RefleXion Medical, a therapeutic oncology...

Posts pagination

← 1 … 9 10 11 12 13 … 20 →

  • Search by Keyword

  • Reset Filter
  • Search by Category

  • Search by Company and Location

© 2025 Healthcare Data News / Powered by WordPress / Theme by Design Lab